Predictive Factors of Discontinuation and Switch of Cholinesterase Inhibitors in Community-Dwelling Patients with Alzheimerʼs Disease-Reference-Cited by-同舟云学术

Predictive Factors of Discontinuation and Switch of Cholinesterase Inhibitors in Community-Dwelling Patients with Alzheimerʼs Disease

Published:2010-05 Issue:5 Volume:24 Page:431-442
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Gardette Virginie,Andrieu Sandrine,Lapeyre-Mestre Maryse,Coley Nicola,Cantet Christelle,Ousset Pierre-Jean,Grand Alain,Monstastruc Jean-Louis,Vellas Bruno

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Reference39 articles.

1. Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

2. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

3. A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer???s Disease

4. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

5. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents;Current Alzheimer Research;2018-08-15

2. Community Pharmacists’ Knowledge Regarding Donepezil Averse Effects and Self-Care Recommendations for Insomnia for Persons with AD;Pharmacy;2017-07-28

3. Medication Adherence in Older Patients With Dementia: A Systematic Literature Review;Journal of Pharmacy Practice;2017-05-24

4. Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany;Journal of Alzheimer's Disease;2017-05-03

5. Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial;Journal of the American Geriatrics Society;2017-03-14